{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,2]],"date-time":"2025-04-02T06:44:01Z","timestamp":1743576241026},"reference-count":16,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,7,18]]},"DOI":"10.7759\/cureus.64856","type":"journal-article","created":{"date-parts":[[2024,7,18]],"date-time":"2024-07-18T19:46:15Z","timestamp":1721331975000},"source":"Crossref","is-referenced-by-count":1,"title":["Elucidating the Neuropsychiatric Phenomena of Antiphospholipid Syndrome in a 31-Year-Old Female"],"prefix":"10.7759","author":[{"given":"Fares","family":"Jamal","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ravina","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Narek","family":"Hakobyan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1002\/art.10187","article-title":"Antiphospholipid syndrome: clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients","volume":"46","author":"Cervera R","year":"2002","unstructured":"Cervera R, Piette JC, Font J, et al.. Antiphospholipid syndrome: clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients. Arthritis Rheum. 2002, 46:1019-27. 10.1002\/art.10187","journal-title":"Arthritis Rheum"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD012169.pub3","article-title":"Antiplatelet and anticoagulant agents for secondary prevention of stroke and other thromboembolic events in people with antiphospholipid syndrome","volume":"10","author":"Bala MM","year":"2020","unstructured":"Bala MM, Celinska-Lowenhoff M, Szot W, Padjas A, Kaczmarczyk M, Swierz MJ, Undas A. Antiplatelet and anticoagulant agents for secondary prevention of stroke and other thromboembolic events in people with antiphospholipid syndrome. Cochrane Database Syst Rev. 2020, 10:CD012169. 10.1002\/14651858.CD012169.pub3","journal-title":"Cochrane Database Syst Rev"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2021005808","article-title":"Apixaban compared with warfarin to prevent thrombosis in thrombotic antiphospholipid syndrome: a randomized trial","volume":"6","author":"Woller SC","year":"2022","unstructured":"Woller SC, Stevens SM, Kaplan D, et al.. Apixaban compared with warfarin to prevent thrombosis in thrombotic antiphospholipid syndrome: a randomized trial. Blood Adv. 2022, 6:1661-70. 10.1182\/bloodadvances.2021005808","journal-title":"Blood Adv"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2002-02-0441","article-title":"Lupus anticoagulants are stronger risk factors for thrombosis than anticardiolipin antibodies in the antiphospholipid syndrome: a systematic review of the literature","volume":"101","author":"Galli M","year":"2003","unstructured":"Galli M, Luciani D, Bertolini G, Barbui T. Lupus anticoagulants are stronger risk factors for thrombosis than anticardiolipin antibodies in the antiphospholipid syndrome: a systematic review of the literature. Blood. 2003, 101:1827-32. 10.1182\/blood-2002-02-0441","journal-title":"Blood"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1007\/s11910-021-01124-z","article-title":"Neurologic manifestations of the antiphospholipid syndrome - an update","volume":"21","author":"Leal Rato M","year":"2021","unstructured":"Leal Rato M, Bandeira M, Rom\u00e3o VC, Aguiar de Sousa D. Neurologic manifestations of the antiphospholipid syndrome - an update. Curr Neurol Neurosci Rep. 2021, 21:41. 10.1007\/s11910-021-01124-z","journal-title":"Curr Neurol Neurosci Rep"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.3390\/brainsci12010091","article-title":"Neuropsychiatric manifestations of antiphospholipid syndrome-a narrative review","volume":"12","author":"Man YL","year":"2022","unstructured":"Man YL, Sanna G. Neuropsychiatric manifestations of antiphospholipid syndrome-a narrative review. Brain Sci. 2022, 12:91. 10.3390\/brainsci12010091","journal-title":"Brain Sci"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.genhosppsych.2017.11.005","article-title":"Association of psychosis with antiphospholipid antibody syndrome: a systematic review of clinical studies","volume":"50","author":"Hallab A","year":"2018","unstructured":"Hallab A, Naveed S, Altibi A, et al.. Association of psychosis with antiphospholipid antibody syndrome: a systematic review of clinical studies. Gen Hosp Psychiatry. 2018, 50:137-47. 10.1016\/j.genhosppsych.2017.11.005","journal-title":"Gen Hosp Psychiatry"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.26022","article-title":"Neurological and neuropsychiatric manifestations of antiphospholipid-antibody syndrome (APS)","volume":"14","author":"Asif S","year":"2022","unstructured":"Asif S, Bali A, Dang AK, Gonzalez DA, Kumar R. Neurological and neuropsychiatric manifestations of antiphospholipid-antibody syndrome (APS). Cureus. 2022, 14:e26022. 10.7759\/cureus.26022","journal-title":"Cureus"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0182344","article-title":"Increased heterogeneity of brain perfusion is an early marker of central nervous system involvement in antiphospholipid antibody carriers","volume":"12","author":"Lin TS","year":"2017","unstructured":"Lin TS, Hsu PY, Chang CH, et al.. Increased heterogeneity of brain perfusion is an early marker of central nervous system involvement in antiphospholipid antibody carriers. PLoS One. 2017, 12:e0182344. 10.1371\/journal.pone.0182344","journal-title":"PLoS One"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1177\/0961203309355300","article-title":"Moderate versus high-titer persistently anticardiolipin antibody positive patients: are they clinically different and does high-titer anti-beta 2-glycoprotein-I antibody positivity offer additional predictive information?","volume":"19","author":"Erkan D","year":"2010","unstructured":"Erkan D, Barbhaiya M, George D, Sammaritano L, Lockshin M. Moderate versus high-titer persistently anticardiolipin antibody positive patients: are they clinically different and does high-titer anti-beta 2-glycoprotein-I antibody positivity offer additional predictive information?. Lupus. 2010, 19:613-9. 10.1177\/0961203309355300","journal-title":"Lupus"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.151.12.1841","article-title":"The antiphospholipid syndrome and psychosis","volume":"151","author":"Kurtz G","year":"1994","unstructured":"Kurtz G, M\u00fcller N. The antiphospholipid syndrome and psychosis. Am J Psychiatry. 1994, 151:1841-2. 10.1176\/ajp.151.12.1841","journal-title":"Am J Psychiatry"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1002\/ccr3.1185","article-title":"Late diagnosis of systemic lupus erythematosus and antiphospholipid syndrome in an older woman with psychosis: a case report and review of the literature","volume":"5","author":"Montero-Olvera PR","year":"2017","unstructured":"Montero-Olvera PR, Berebichez-Fridman R, Vel\u00e1zquez-\u00c1lvarez L, R\u00edos-Morales JR, Rodr\u00edguez-Guiza MA. Late diagnosis of systemic lupus erythematosus and antiphospholipid syndrome in an older woman with psychosis: a case report and review of the literature. Clin Case Rep. 2017, 5:1819-25. 10.1002\/ccr3.1185","journal-title":"Clin Case Rep"},{"key":"ref13","article-title":"Evaluation of regional cerebral blood flow with 99mTc-HMPAO in primary antiphospholipid antibody syndrome","volume":"40","author":"Kao CH","year":"1999","unstructured":"Kao CH, Lan JL, Hsieh JF, Ho YJ, ChangLai SP, Lee JK, Ding HJ. Evaluation of regional cerebral blood flow with 99mTc-HMPAO in primary antiphospholipid antibody syndrome. J Nucl Med. 1999, 40:1446-50.","journal-title":"J Nucl Med"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0447.1993.tb03349.x","article-title":"Autoimmunity in depression: increased antiphospholipid autoantibodies","volume":"87","author":"Maes M","year":"1993","unstructured":"Maes M, Meltzer H, Jacobs J, Suy E, Calabrese J, Minner B, Raus J. Autoimmunity in depression: increased antiphospholipid autoantibodies. Acta Psychiatr Scand. 1993, 87:160-6. 10.1111\/j.1600-0447.1993.tb03349.x","journal-title":"Acta Psychiatr Scand"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1002\/art.22802","article-title":"Anti-beta2-glycoprotein I antibodies induce monocyte release of tumor necrosis factor alpha and tissue factor by signal transduction pathways involving lipid rafts","volume":"56","author":"Sorice M","year":"2007","unstructured":"Sorice M, Longo A, Capozzi A, et al.. Anti-beta2-glycoprotein I antibodies induce monocyte release of tumor necrosis factor alpha and tissue factor by signal transduction pathways involving lipid rafts. Arthritis Rheum. 2007, 56:2687-97. 10.1002\/art.22802","journal-title":"Arthritis Rheum"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/j.thromres.2020.10.010","article-title":"Thrombotic antiphospholipid syndrome: a practical guide to diagnosis and management","volume":"198","author":"Sayar Z","year":"2021","unstructured":"Sayar Z, Moll R, Isenberg D, Cohen H. Thrombotic antiphospholipid syndrome: a practical guide to diagnosis and management. Thromb Res. 2021, 198:213-21. 10.1016\/j.thromres.2020.10.010","journal-title":"Thromb Res"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/190360-elucidating-the-neuropsychiatric-phenomena-of-antiphospholipid-syndrome-in-a-31-year-old-female","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,18]],"date-time":"2024-07-18T19:46:18Z","timestamp":1721331978000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/190360-elucidating-the-neuropsychiatric-phenomena-of-antiphospholipid-syndrome-in-a-31-year-old-female"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,18]]},"references-count":16,"URL":"https:\/\/doi.org\/10.7759\/cureus.64856","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7,18]]}}}